Cardiovascular Manifestations From Therapeutic Radiation
Joshua D. Mitchell(Washington University in St. Louis), Susan Dent(Government of the United States of America), D. Cehic(Australian and New Zealand Intensive Care Society), Vlad G. Zaha(Southwestern Medical Center), Carmen Bergom(Washington University in St. Louis), Marita Morgia(Royal North Shore Hospital), Juan Lopez‐Mattei(The University of Texas MD Anderson Cancer Center), Robin Kikuchi(University of Southern California), Joanne Toohey(St Vincent's Hospital Sydney), Andrés J. Daniele(Universidad de Buenos Aires), Patricia A. Guerrero(AdventHealth Orlando), Daniel J. Lenihan(Saint Francis Medical Center), Jose Alvarez‐Cardona(Washington University in St. Louis), Joseph R. Carver(American Society of Clinical Oncology), Maros Ferencik(Tufts Medical Center), Lili Zhang(Sun Yat-sen University), Anju Nohria(Brigham and Women's Hospital), Jörg Herrmann(Mayo Clinic), Sebastian Szmit
Cited by 201
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k